R Ignoffo

850 total citations
7 papers, 633 citations indexed

About

R Ignoffo is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R Ignoffo has authored 7 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R Ignoffo's work include Pancreatic and Hepatic Oncology Research (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). R Ignoffo is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). R Ignoffo collaborates with scholars based in United States. R Ignoffo's co-authors include B.J. Lewis, Michael Friedman, Robert Stagg, Anthony A. Rayner, David C. Hohn, John F. Hannigan, Douglas G. Altman, D. Höhn, Joel Z. Melnick and Marylin J. Dodd and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Practice and PubMed.

In The Last Decade

R Ignoffo

7 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R Ignoffo United States	6	385	361	225	224	81	7	633
D. Lepillé France	9	198 0.5×	87 0.2×	104 0.5×	133 0.6×	7 0.1×	12	360
Durgatosh Pandey India	11	157 0.4×	123 0.3×	121 0.5×	307 1.4×	14 0.2×	42	484
Carlo Gazzera Italy	16	133 0.3×	312 0.9×	156 0.7×	239 1.1×	12 0.1×	42	592
Woo Kun Kim South Korea	13	376 1.0×	78 0.2×	242 1.1×	107 0.5×	6 0.1×	36	643
D. Braumann Germany	14	331 0.9×	174 0.5×	165 0.7×	135 0.6×	4 0.0×	28	568
Juan W Zinser Mexico	9	206 0.5×	55 0.2×	136 0.6×	36 0.2×	17 0.2×	19	374
Hong Wu China	18	413 1.1×	477 1.3×	198 0.9×	453 2.0×	5 0.1×	58	911
KC Lakshmaiah India	13	324 0.8×	31 0.1×	184 0.8×	70 0.3×	41 0.5×	74	563
Yinglong Xu China	9	134 0.3×	572 1.6×	136 0.6×	387 1.7×	13 0.2×	18	940
Koroush S. Haghighi Australia	12	168 0.4×	98 0.3×	155 0.7×	244 1.1×	10 0.1×	38	494

Countries citing papers authored by R Ignoffo

Since Specialization

Citations

This map shows the geographic impact of R Ignoffo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Ignoffo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Ignoffo more than expected).

Fields of papers citing papers by R Ignoffo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Ignoffo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Ignoffo. The network helps show where R Ignoffo may publish in the future.

Co-authorship network of co-authors of R Ignoffo

This figure shows the co-authorship network connecting the top 25 collaborators of R Ignoffo. A scholar is included among the top collaborators of R Ignoffo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Ignoffo. R Ignoffo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ignoffo, R, et al.. (1998). Angiogenesis inhibitors. A promising role in cancer therapy.. Cancer Practice. 6(1). 60–62. 7 indexed citations

2.

Hui, Yan & R Ignoffo. (1997). Dolasetron. A new 5-hydroxytryptamine3 receptor antagonist.. PubMed. 5(5). 324–8. 1 indexed citations

3.

Dodd, Marylin J., Patricia J. Larson, Suzanne L. Dibble, et al.. (1996). Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy.. PubMed. 23(6). 921–7. 130 indexed citations

4.

Hohn, David C., Robert Stagg, Michael Friedman, et al.. (1989). A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.. Journal of Clinical Oncology. 7(11). 1646–1654. 349 indexed citations

5.

Höhn, D., Joel Z. Melnick, Robert Stagg, et al.. (1985). Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.. Journal of Clinical Oncology. 3(1). 98–102. 122 indexed citations

6.

Benz, Christopher C., Michael W. DeGregorio, S. Saks, et al.. (1985). Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response.. PubMed. 45(7). 3354–8. 17 indexed citations

7.

Ds, Alberts & R Ignoffo. (1978). Adriamycin-cyclophosphamide treatment of squamous cell carcinoma of the cervix.. PubMed. 62(1). 143–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact